The Ophthalmology CRO for Biotech, Powered by Technology

Delivering faster, better, cheaper ophthalmology trial results for biotech sponsors.

Our Ophthalmology CRO Executive Team

Our Ophthalmology CRO team's expertise spans across indications with prior experience at both large and small CROs

Our experienced CRO executive team works closely with our expert site operations team to continuously review execution strategies, closely monitor patient recruitment efforts, and mitigate key study risks for Ophthalmology clinical trials.

Powered By Our Connected Technology Platform

The Vial Technology Platform leverages connected systems and intuitive design to run global trials efficiently at scale

A diagram of an oncology healthcare technology platform.
A diagram of the oncology technology platform.

Vial’s modern technology platform brings clinical trials out of the paper stone age, allowing for streamlined processes inside one end-to-end system.

no-nonsense pricing

Vial offers sponsors fixed-pricing agreements with no change orders — ever.

A line icon of a dollar sign and a price tag representing the cost of oncology services provided by a Contract Research Organization (CRO).

Flat-rate pricing

A fixed-fee pricing model guarantees a set budget for the entirety of a project, regardless of the time and expense that accrues.

Two arrows pointing in different directions, representing conflicting perspectives.

Zero change orders

Thorough planning, an experienced team, and our next-gen technology platform allow us to proactively prepare for and avert common errors or delays.

An oncology icon with gears and a warning sign.

Risk-share on commitments

We focus on delivering results that matter, and our risk share on commitments approach underscores our dedication to your trial's success.

Fast Start-up and Consolidated Site Activation

Vial’s Site Startup Platform enables sites to seamlessly onboard to our trials

The Result: Self-service onboarding eliminating administrative burden and increasing progress transparency.

Scientific Advisory Board

Experience across Ophthalmology

The Vial CRO is supported by a team of ophthalmic scientific advisors who provide expert input to advance ophthalmology research.

More than 10 years as a Vitreo-Retinal Physician and Surgeon, as well as Director of Clinical Research at his practice, Sierra Eye Associates
Director of Retina Services at the Pepose Vision Institute
VP of Clinical Development and Ophthalmology Lead at Rezolute, Inc. and the founder, president, and CEO of an international nonprofit, Retina Global

Discover insights to help you run trials faster and more efficiently.

Articles

Patient Recruitment in 2023: What Works and What Doesn’t in Clinical Trial Enrollment

Events / January 8-11, 2024 / San Francisco, CA

Vial will be at the 42nd Annual J.P. Morgan Healthcare Conference

Whitepapers

A Closer Look at Value-Based Healthcare in Oncology

Podcast

First in Human Episode #44 featuring Max Darnell

Articles

AI-Designed Drugs vs. Traditional Drug Discovery: Pros and Cons

Podcast

First in Human Episode #38 featuring Stephen Doyle

why the vial ophthalmology cro?

Streamlined trial startup, more predictable patient recruitment, and higher quality data.

Vial understands the nuances in running Ophthalmology clinical trials and have built a team of in-house Ophthalmologists with decades of combined experience across anterior and posterior segments.

Our advisors’ experience in every Ophthalmology clinical trial indication, combined with a preferred site network of top-tier ophthalmologists, allow for a fully integrated Ophthalmology CRO that offers faster trial startup, superior patient recruitment, and better quality data.

A woman intently examines an eye exam displayed on a computer screen, focusing on the visual test.
An elderly man is having his eyes examined by an optometrist specialized in oncology.

Connect with us.

Interested in receiving a proposal from Vial? Leave us a message and some of your contact info and we’ll be in touch with you shortly.

Name(Required)
By submitting, you are agreeing to our terms and privacy policy
This field is for validation purposes and should be left unchanged.